Clinical Reference
Blood Disorder Information
Comprehensive clinical information authored by Dr. Suparno Chakrabarti and Dr. Mahak Agarwal.
Find Your Condition
Select a category to learn about specific conditions and how we treat them.
Genetic Blood Disorders
Blood Cancers
Acute Lymphoblastic Leukemia
Commonest childhood cancer. 90% of standard-risk children cured with chemotherapy.
→ Blood CancerAcute Myeloid Leukemia
BMT reduces relapse risk by 80% compared to chemotherapy alone.
→ Blood CancerChronic Myeloid Leukemia
Targeted therapy with TKIs. BMT for resistant or accelerated phase disease.
→ Blood CancerChronic Lymphocytic Leukemia (CLL)
A B-cell leukemia ranging from indolent to aggressive; treated with targeted oral therapy, and BMT or CAR-T for high-risk and relapsed disease.
→ Plasma Cell CancerMultiple Myeloma
A cancer of plasma cells in the bone marrow, treated with targeted drugs, autologous BMT, and CAR-T cell therapy.
→Lymphomas & MDS
Hodgkin's Lymphoma
Highly treatable cancer with >95% cure rate in limited disease. BMT for relapsed cases.
→ LymphomaNon-Hodgkin's Lymphoma
Diverse group of lymphoid cancers. 70% cure rate with Haploidentical BMT in relapsed/high-risk cases.
→ Bone Marrow DisorderMyelodysplastic Syndromes
Allogeneic BMT is the only curative treatment. Best results when done early.
→Bone Marrow & Immune Disorders
Aplastic Anemia
Bone marrow stops producing blood cells. BMT cures 90% of patients when done early.
→ Bone Marrow FailureInherited Bone Marrow Failure
Fanconi Anemia, DKC, SDS and others. 70–80% cure rates with Allogeneic BMT.
→ Immune DisorderAutoimmune Diseases
BMT can 'reboot' the immune system. Most promising for Scleroderma and Multiple Sclerosis.
→ PediatricPrimary Immunodeficiency
Nearly 100% cure rate with T cell depleted Haploidentical BMT in our experience.
→ PediatricInherited Metabolic Disorders
BMT from healthy donor populates body with enzyme-producing cells, improving organ function.
→